首页> 外文期刊>Oncology Research >Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway
【24h】

Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway

机译:长度非编码RNA PlNcrNA-1通过调节PI3K / AKT信号通路来促进结肠直肠癌细胞进展

获取原文
获取原文并翻译 | 示例
       

摘要

Accumulating evidence has indicated that long noncoding RNA (lncRNA) PlncRNA-1 plays an important regulatory role in cancers. However, the expression and biological functions of PlncRNA-1 in colorectal cancer (CRC) are still unclear. In the present study, we determined the expression of PlncRNA-1 in CRC and explored the function of PlncRNA-1 on CRC cell progression. The results showed that PlncRNA-1 was significantly increased in CRC tissues and cell lines: high PlncRNA-1 expression was associated with depth of invasion, lymph node metastasis, and TNM stage of CRC patients. Kaplan-Meier curve analysis showed that patients with high PlncRNA-1 expression had a poor overall survival. PlncRNA-1 knockdown remarkably reduced cell proliferation, migration, and invasion and promoted cell apoptosis in vitro. In vivo xenograft experiments showed that PlncRNA-1 inhibition significantly suppressed tumor growth. Finally, we used an agonist (740Y-P) of the PI3K/Akt signaling pathway; function assays showed that PlncRNA-1 exerted its effects by targeting the PI3K/Akt signaling pathway in CRC. Taken together, our data suggested that PlncRNA-1 might act as an oncogene in CRC progression and serve as a potential biomarker and therapeutic target for the treatment of CRC.
机译:累积证据表明,长度非编码RNA(LNCRNA)PLNCRNA-1在癌症中发挥着重要的监管作用。然而,结直肠癌(CRC)中PLNCRNA-1的表达和生物学功能仍然不清楚。在本研究中,我们确定了CRC中PLNCRNA-1的表达,并探讨了PLNCRNA-1对CRC细胞进展的功能。结果表明,CRC组织和细胞系中PLNCRNA-1显着增加:高PLNCRNA-1表达与CRC患者的侵袭深度,淋巴结转移和TNM阶段相关。 Kaplan-Meier Curve分析显示,具有高plncrna-1表达的患者的整体存活率差。 PLNCRNA-1敲低的细胞增殖,迁移和侵袭和促进细胞凋亡的敲低。体内异种移植实验表明,PlNcRNA-1抑制显着抑制了肿瘤生长。最后,我们使用了PI3K / AKT信号传导途径的激动剂(740Y-P);功能测定表明,通过靶向CRC中的PI3K / AKT信号通路来施加其效果。我们的数据表明,PLNCRNA-1可以作为CRC进展中的癌基因,作为潜在的生物标志物和治疗CRC的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号